Effect of Shock Wave Therapy on Upper Trapezius Trigger Points in Patients With Cervicogenic Headache.

Cervicogenic Headache Clinical Trial

Official title:

Effect of Shock Wave Therapy on Upper Trapezius Trigger Points in Patients With Cervicogenic Headache. a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05939583
• Other study ID #: REC/2111/MTI.PT/2303123
• Status: Completed
• Phase: N/A
• Start date: February 1, 2022
• Est. completion date: February 1, 2023

Study information

• Verified date: March 2024
• Source: October 6 University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Control group will receive US, TENS, IR and exercises. The treatment group will receive the same program in addition to shock waves therapy. Patients will receive 3 sessions per week for 4 weeks.

Description:

Control group will receive US, TENS, IR and exercises. The treatment group will receive the same program in addition to shock waves therapy. Patients will receive 3 sessions per week for 4 weeks.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50
• Est. completion date: February 1, 2023
• Est. primary completion date: September 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

• Fifty patients from both genders.
• Age ranging from 20 to 40 years.
• Referred by an orthopedist with a diagnosis of Mechanical neck dysfunction (MND) to physical therapy at the outpatient clinic of the Faculty of Physical Therapy, MTI University.

Exclusion Criteria:

• All other disorders.

Related Conditions & MeSH terms

• Cervicogenic Headache
• Headache
• Post-Traumatic Headache

Intervention

Other:
• Shock Wave Therapy
Receiving Shock wave therapy + US, TENS, IR and exercises.
• US, TENS, IR and exercises.
Receiving US, TENS, IR and exercises only.

Locations

Country	Name	City	State
Egypt	October 6 University	El-Sheikh Zayed City	Giza

Sponsors (1)

Lead Sponsor	Collaborator
October 6 University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual analogue scale	Assess degree of pain from 1 (No Pain) to 10 (Severe Pain)	4 weeks
Primary	Neck disability index	Assess degree of neck disability.	4 weeks
Primary	Kinesiological EMG	Analysis of root mean square for upper trapezius muscle functions.	4 weeks
Primary	Kinesiological EMG	Analysis of median frequency for upper trapezius muscle functions.	4 weeks